期刊文献+

丙戊酸钠联合顺铂对HO-8910细胞增殖的影响及机制

Effect of sodium valproate combined with cisplatin on proliferation of HO-8910 cells and the mechanism
原文传递
导出
摘要 目的:探讨丙戊酸钠(VPA)联合顺铂(DDP)对体外培养的人卵巢癌细胞HO-8910细胞增殖抑制和凋亡作用及机制。方法:3 mM浓度的VPA、1μg/m l的DDP及VPA联合DDP分别处理人卵巢癌细胞株HO-8910不同时间(24、48、72 h)后,采用MTT法检测细胞的增殖活性;Hoechst 33258荧光染色观察细胞凋亡形态学改变;RT-PCR检测p53基因mRNA水平表达变化;W estern b lot法检测p53及Stat3蛋白表达变化。结果:VPA对卵巢癌HO-8910细胞株有生长抑制作用,且VPA联合DDP优于单独用药(P<0.05);Hochest 33258荧光染色结果显示,用药后细胞呈现明显的核碎裂、核固缩等典型凋亡改变,VPA联合DDP组细胞凋亡改变较单独用药组明显(P<0.05);RT-PCR检测显示VPA单独用药及联合DDP用药均能提高p53基因的mRNA表达水平;W estern b lot结果显示VPA联合DDP显著增强卵巢癌HO-8910细胞中p53蛋白表达,降低Stat3蛋白的表达,联合用药组效果更明显。结论:VPA单独用药在体外可有效杀伤卵巢癌HO-8910细胞株,与DDP联合应用具有明显的协同作用,推测其可能的作用机制是诱导p53表达水平上调及Stat3表达水平下调。 Objective:To explore the inhibiting effect of sodium valproate combined with cisplatin on proliferation and apoptosis of human ovarian cancer HO-8910 cells in vitro and the mechanism.Methods:Sodium valproate of 3 mM,cisplatin of 1 μg/ml and sodium valproate combined with cisplatin were used to treat human ovarian cancer HO-8910 cells for 24,48 and 72 hours,respectively,then MTT was used to detect the proliferative activity of HO-8910 cells;Hoechst 33258 fluorescence staining was used to observe the morphological changes of cell apoptosis;the change of expression level of p53 gene mRNA was detected by RT-PCR;Western blot was used to detect the changes of expression levels of p53 and stat3 protein.Results:Sodium valproate inhibited the proliferation of human ovarian cancer HO-8910 cells,the clinical efficacy of sodium valproate combined with cisplatin was superior to those of single sodium valproate and single cisplatin(P〈0.05);the results of Hoechst 33258 fluorescence staining showed that typical apoptotic changes including karyorrhexis and karyopyknosis appeared after treatment,and the apoptotic changes in sodium valproate combined with cisplatin group was more obvious than those in single sodium valproate group and single cisplatin group(P〈0.05);RT-PCR analysis showed that single sodium valproate and sodium valproate combined with cisplatin both increased the expression level of P53 gene mRNA.Western blot analysis showed that sodium valproate combined with cisplatin increased the expression of P53 protein in human ovarian cancer HO-8910 cells,reduced the expression of Stat3 protein,and the effect was more obvious in sodium valproate combined with cisplatin group.Conclusion:Single usage of sodium valproate can inhibit the proliferation of human ovarian cancer HO-8910 cells in vitro,and sodium valproate combined with cisplatin plays an obvious synergistic effect,it is speculated that the possible mechanism is induction of p53 up-regulation and Stat3 down-regulation.
出处 《中国妇幼保健》 CAS 北大核心 2011年第16期2513-2516,共4页 Maternal and Child Health Care of China
基金 安徽省2008年科技攻关计划重大科技专项项目〔NO.08010302101〕
关键词 卵巢肿瘤 丙戊酸钠 顺铂 细胞凋亡 Ovarian cancer Sodium valproate Cisplatin Cell apoptosis
  • 相关文献

参考文献10

  • 1Dundr P. Ovarian carcinoma: current diagnostic principles [J]. Cesk Patol, 2010. 46 (3): 53.
  • 2Sedl6kov6 I, Tosner J, Rez0c A et al. Resistance/sensitivity in vitro in ovarian cancer patients[J]. Ceska Gynekol, 2010, 75 (3) : 182.
  • 3Wagner JM, Bug G, Jung M. Valproic acid as a histone deacetylase in- hibitor. New application for a well - known drug [J]. Pharmazie in UnsererZeit, 2010, 39 (3): 197.
  • 4Shabbeer S, Kortenhorst MS, Kachhap Set al. Multiple molecular pathways explain the anti - proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo [J]. Prostate, 2007, 67 (10) :1099.
  • 5Batty N, Malouf GG, Issa JP et al. Histone deacetylase inhibitors as anti -neoplastic agents[J].Cancer Lett, 2009, 280 (2) : 192.
  • 6Sawan C, Herceg Z. Histone modifications and cancer [J]. Adv Genet, 2010, 70:57.
  • 7Tapia N, Scholer HR. p53 connects tumorigenesis and reprogramming to pluripotency [J] . J Exp Med, 2010, 207 (10): 2045.
  • 8Condorelli F, Gnemmi I, Vallario Aet al. Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells [J]. Br J Pharmacol, 2008, 153 (4): 657.
  • 9Tao H, Zhu Y, Wang H et al. Effects of p53 gene on drug resistance in human lung cancer cell lines[J].Zhongguo Fei Ai Za Zhi, 2008 , 11 (2): 157.
  • 10Niu G, Wright KL, Ma Y et al. Role of Star3 in regulating p53 expression ,and function [J]. Mol Cell Biol, 2005 , 95 (17) : 7432.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部